Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.075 AUD -5.06%
Market Cap: 46.9m AUD

Intrinsic Value

The intrinsic value of one MDR stock under the Base Case scenario is 0.181 AUD. Compared to the current market price of 0.075 AUD, Medadvisor Ltd is Undervalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDR Intrinsic Value
0.181 AUD
Undervaluation 59%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Medadvisor Ltd

What is Valuation History?
Compare MDR to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MDR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Medadvisor Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medadvisor Ltd

Current Assets 29.6m
Cash & Short-Term Investments 12.4m
Receivables 14.5m
Other Current Assets 2.6m
Non-Current Assets 70.7m
Long-Term Investments 1.9m
PP&E 1.5m
Intangibles 67.3m
Other Non-Current Assets 30.2k
Efficiency

Free Cash Flow Analysis
Medadvisor Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medadvisor Ltd

Revenue
103.7m AUD
Cost of Revenue
-37.9m AUD
Gross Profit
65.8m AUD
Operating Expenses
-68.2m AUD
Operating Income
-2.5m AUD
Other Expenses
-2.2m AUD
Net Income
-4.7m AUD
Fundamental Scores

MDR Profitability Score
Profitability Due Diligence

Medadvisor Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Operating Margin is Increasing
39/100
Profitability
Score

Medadvisor Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

MDR Solvency Score
Solvency Due Diligence

Medadvisor Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
45/100
Solvency
Score

Medadvisor Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDR Price Targets Summary
Medadvisor Ltd

Wall Street analysts forecast MDR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDR is 0.136 AUD with a low forecast of 0.101 AUD and a high forecast of 0.2 AUD.

Lowest
Price Target
0.101 AUD
35% Upside
Average
Price Target
0.136 AUD
81% Upside
Highest
Price Target
0.2 AUD
166% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Medadvisor Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MDR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MDR stock?

The intrinsic value of one MDR stock under the Base Case scenario is 0.181 AUD.

Is MDR stock undervalued or overvalued?

Compared to the current market price of 0.075 AUD, Medadvisor Ltd is Undervalued by 59%.

Back to Top